HANDS Act
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
The HANDS Act amends Medicare, Medicaid, and TRICARE to provide no-cost coverage of opioid overdose reversal drugs (naloxone) when distributed preventively to at-risk individuals at hospitals, emergency departments, and ambulatory surgical centers upon discharge. The bill eliminates cost-sharing, deductibles, and copayments for these drugs under all three programs beginning January 1, 2026, and directs the FDA and HHS to issue guidance to states and hospitals on safe dispensing and billing practices.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.